Thomas Kipps
Institution Name:
University of California, San Diego
Total Awards:
2
Award Value:
$22,472,272
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Disease Team Therapy Development III | University of California, San Diego | Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab) | $4,179,598 |
| Clinical Trial Stage Projects | University of California, San Diego | A Phase 1b/2a Study of the ROR1-Targeting Monoclonal Antibody, Cirmtuzumab, and the Bruton Tyrosine Kinase Inhibitor, Ibrutinib, in B-Cell Cancers | $18,292,674 |
Total: $22,472,272.00 |